Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tenofovir Alafenamide Fumarate”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Post-approval studies (Phase 4)UnknownNCT05122754
What this trial is testing

Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection

Who this might be right for
HIV-1-infection
Shanghai Public Health Clinical Center 150
Not applicableUnknownNCT03566030
What this trial is testing

Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance

Who this might be right for
Hepatitis BAntiviral Drug Adverse Reaction
Yonsei University 300
Post-approval studies (Phase 4)Not Yet RecruitingNCT06221657
What this trial is testing

Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment

Who this might be right for
Patients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication
Yonsei University 100
Large-scale testing (Phase 3)Study completedNCT03110380
What this trial is testing

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed

Who this might be right for
HIV-1-infection
Gilead Sciences 567
Not applicableUnknownNCT04211805
What this trial is testing

Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B

Who this might be right for
Hepatitis B, ChronicPregnancy Related
New Discovery LLC 450
Early research (Phase 1)Study completedNCT07295873
What this trial is testing

Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide

Who this might be right for
Chronic Hepatitis B Liver FibrosisDDI (Drug-Drug Interaction)
Beijing Continent Pharmaceutical Co, Ltd. 64
Not applicableLooking for participantsNCT06947356
What this trial is testing

Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads

Who this might be right for
Hepatitis B
Guangzhou 8th People's Hospital 210
Large-scale testing (Phase 3)Study completedNCT02836249
What this trial is testing

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)

Who this might be right for
HBVChronic HBV Infection
Gilead Sciences 181
Testing effectiveness (Phase 2)Study completedNCT03251144
What this trial is testing

Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)

Who this might be right for
HIV/AIDSAntiviral ToxicityAntiviral Drug Adverse Reaction+1 more
University of California, Los Angeles 26
Not applicableWithdrawnNCT03405194
What this trial is testing

Same-Day Treatment With Genvoya vs. EFV/TDF/3TC

Who this might be right for
HIV/AIDS
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Testing effectiveness (Phase 2)Study completedNCT03115736
What this trial is testing

TAF for HIV-HBV With Renal Dysfunction

Who this might be right for
HIV and Hepatitis B Coinfection
Insel Gruppe AG, University Hospital Bern 24
Large-scale testing (Phase 3)Study completedNCT01940471
What this trial is testing

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Positive for Hepatitis B e Antigen

Who this might be right for
HBeAg-positive Chronic Hepatitis B
Gilead Sciences 875
Testing effectiveness (Phase 2)Study completedNCT03180619
What this trial is testing

Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 124
Early research (Phase 1)Study completedNCT05489406
What this trial is testing

Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS.

Who this might be right for
Hiv
Radboud University Medical Center 16
Large-scale testing (Phase 3)Study completedNCT03405935
What this trial is testing

Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years

Who this might be right for
HIV-1 Infection
Gilead Sciences 86
Post-approval studies (Phase 4)Looking for participantsNCT05853718
What this trial is testing

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

Who this might be right for
Chronic Hepatitis bTenofovir Alafenamide Fumarate
First People's Hospital of Hangzhou 50
Large-scale testing (Phase 3)Study completedNCT02652624
What this trial is testing

Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women

Who this might be right for
HIV-1 Infection
Gilead Sciences 472
Testing effectiveness (Phase 2)Study completedNCT05993767
What this trial is testing

UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children

Who this might be right for
HIV Infection
PENTA Foundation 53
Post-approval studies (Phase 4)Ended earlyNCT03532425
What this trial is testing

B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults

Who this might be right for
HIV-1-infection
University of Alberta 28
Large-scale testing (Phase 3)Study completedNCT02269917
What this trial is testing

Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants

Who this might be right for
Human Immunodeficiency Virus Type 1
Janssen R&D Ireland 1,149
Next Page